Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn about a recent article he and Daniel Added co-authored published in JACC Journals, adding:
“In this editorial published in JACC Asia, Daniel Added and I comment on the results of the study by Puri et al., which evaluated attainment of LDL-C goals in Indian patients.
Unfortunately as seen in other countries most patients remained with still high LDL-C values despite the use of statin therapy in most of them.
Nowadays, it has been shown that more intensive cholesterol lowering to values around 30-40 mg/dL further reduces cardiovascular events in comparison with values around 90 mg/dL.
There is a need for access to additional cholesterol-lowering medications, such as ezetimibe, bempedoic acid, and PCSK9 inhibitors like evolocumab, alirocumab, and inclisiran to adequately control LDL-C and reduce the burden of ASCVD events.
Hopefully, the arrival of oral PCSK9 inhibitors like enlicited and laroprovastat will increase access to these therapies.”
Title: LDL-C Remains Elevated in Patients With Very High Cardiovascular Risk in India and Elsewhere
Authors: Daniel A. Added, Raul D. Santos
Title: Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease: A Nationwide Study
Authors: Raman Puri, Manish Bansal, Kunal Mahajan, Rajeev Gupta, Vimal Mehta, Shamanna S. Iyengar, Dorairaj Prabhakar, Rajeev Agarwala, Aziz Khan, Neil Bordoloi, Nagaraj Desai, Sheeba George, Biswajit Majumder, Smit Shrivastava, Vinod Vijan, Asha Mahilmaran, Dharmendra Jain, Sadanand R. Shetty, P. Barton Duell, Nathan D. Wong
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 2, 2026, 15:16Tim Patel: How Regular Movement Helps Keep Blood Flowing Throughout the Day
-
Jul 2, 2026, 13:16Nathan Connell: Is It Time to Rethink What We Tell Hemophilia B Carriers About Pregnancy?
-
Jul 2, 2026, 13:09Bruce Ovbiagele: WSO SCDKIDS Task Force’s Webinar Sheds Light On Care of Sickle Cell Disease-Related Stroke
-
Jul 2, 2026, 12:55Taraneh G. Farazi: The Latest Stroke Clinician Issue Highlights the Importance of Patient Voices in Dysphagia Care
-
Jul 2, 2026, 12:45Kaveh Mehrvar: The Gut–Brain Axis May Hold New Clues to Stroke Pathophysiology
-
Jul 2, 2026, 12:28Expanding Stroke Education Through Mobile Stroke Clinics – Ethiopia Stroke Foundation
-
Jul 2, 2026, 11:52Praveen Kumar Tirlangi: A New Mechanism of Bleeding in Kyasanur Forest Disease
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis
-
Jul 2, 2026, 11:17Neeraj Jain: Maharashtra Is Setting the Pace for Integrated Hemoglobinopathy Care